Cargando…
Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
The recent decrease in mortality related to cardiovascular diseases has largely been due to the more effective treatment of cardiovascular risk factors and secondary prevention therapies. More people than ever are now on long-term medications. Hypertension, which is one of the most common cardiovasc...
Autores principales: | Battistoni, Allegra, Volpe, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215559/ https://www.ncbi.nlm.nih.gov/pubmed/32419852 http://dx.doi.org/10.15420/ecr.2019.21 |
Ejemplares similares
-
Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
por: Godoy, Lucas C, et al.
Publicado: (2019) -
Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis
por: Shin, Young Eun, et al.
Publicado: (2023) -
AF in Cancer Patients: A Different Need for Anticoagulation?
por: Sanz, Ana Pardo, et al.
Publicado: (2019) -
Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013) -
Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)